Gail S. Thornton, PhD(c),  Contributing Editor, Author and Medical Writer, Marketing Communications

11/10/2020

Selected Projects:

1. Podcast Schedule https://pharmaceuticalintelligence.com/audio-podcasts/

Development Plan for e-VOICES Podcasting, 2019 – 2021*

https://pharmaceuticalintelligence.com/audio-podcasts/

Podcast Interviewer	INTERVIEWEE(S)	Subject	Date	Audio/Video/ Narrator
Gail S. Thornton	Dr. Stephen J. Williams, Dr. Irina Robu & Dr. Aviva Lev-Ari	3D BioPrinting in Medicine	5/2019	Audio
Gail S. Thornton	Prof. Feldman	Evolution Biology and Population Genetics	3/17/2020	Audio
Gail S. Thornton	Dr. Larry H. Bernstein, MD, FCAP	Life Memoirs in Clinical Pathology Told	10/12/2020	Audio Narrator: Dr. S.J. Williams
Gail S. Thornton	Dr. Sudipta Saha	Research in Reproductive Technology	11/7/2020	Audio
Gail S. Thornton	Dr. Justin D. Pearlman, MD, PhD	Cardiac Imaging – Evolution of Diagnostic Methods	4Q 2020	Audio
Gail S. Thornton	Dr. Raphael Nir	From Big Pharma to Biotech Entrepreneurship	2021	Audio
Gail S. Thornton	Dr. Meg Baker	GlycoBiology in Practice	2021	Audio
Gail S. Thornton	Dr. Ofer Markman	Memories of Procognia	2021	Audio
Gail S. Thornton	Dr. Irina Robu	AI & Tissue Engineering	2021	Audio
Gail S. Thornton	Dr. Williams	Preferably 3rd party interviewer sourced AI & Genomics by Gail	2021	Audio
Gail S. Thornton	Dr. Aviva Lev-Ari	Preferably 3rd party interviewer sourced Curation & ML by Gail	2021	Audio

2. Schedule for 2021 Newsletters posted  https://pharmaceuticalintelligence.com/newsletter/

3. New 2.0 LPBI Website Design with Aviva and INTERN starting 12/2020.

BIO

Gail S. Thornton

Chester, New Jersey 07930

908-879-9295 (Home)

908-392-3420 (Mobile)

gailsthornton@yahoo.com

gst@worldviewcomms.com

 

GLOBAL COMMUNICATIONS / PUBLIC RELATIONS

Accomplished communications executive with global experience in pharmaceuticals/health care and biotechnology.

• Adviser to business partners and C-suite executives;
• Strategic, collaborative and outcomes-oriented leader;
• Consistent producer of results that further strategic objectives, engage stakeholders and strengthen company and brand reputation; and
• Proven expertise in up-leveling global communications functions, creating high-performing global teams.

Demonstrated track record in developing and leading U.S. and international communications to support business strategy and priorities, including executive, acquisition/partnerships, corporate reputation, manufacturing milestones, franchise public relations, media relations/social media, employee communications, crisis and issues management and industry analyst relations.

Provide high-level counsel to business leaders and executives. Establish thought-leadership platforms for executive, company reputation activities and product communications campaigns.

Experience in recruiting and developing talent globally and leading high-performing teams to evolve the communications function to anticipate and stay ahead of business needs. Skilled at building and cultivating a network of global media.

Publications with Leaders in Pharmaceutical Business Intelligence (LPBI) Group

• Contributing Editor, Medical Writer and Author, Leaders in Pharmaceutical Business Intelligence (LPBI) Group (2015 – Present).
• Editor/author of medical textbook, The Voices of Patients, Hospital CEOs, Health Care Providers, Caregivers and Families: Personal Experience with Critical Care and Invasive Medical Procedures, eds. Aviva Lev-Ari, Ph.D., R.N., and Gail S. Thornton, M.A., including 12 compelling patient stories related to invasive medical procedures as well as CEO and scientific leader interviews within hospitals, academic institutions and pharma/biotech companies. (Offered on Amazon and Kindle in October 2017 –https://www.amazon.com/dp/B076HGB6MZ).
• Author of four articles in medical textbook, Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology, eds. Aviva Lev-Ari, Ph.D., R.N., Marcus Feldman, Ph.D. and Stephen Williams, Ph.D. (Offered on Amazon and Kindle in January 2020 –https://www.amazon.com/dp/B08385KF87).
• Author of book chapter on patient story related to cardiovascular disease published in Interventional Cardiology for Disease Diagnosis and Cardiac Surgery for Condition Treatment, eds. Justin D. Pearlman, M.D., Larry H. Bernstein, M.D., Aviva Lev-Ari, Ph.D., R.N. (Offered on Amazon and Kindle in December 2018 –https://www.amazon.com/dp/B07MKHDBHF).

Curriculum Vitae

Contributions in 2020

Gail S. Thornton, MA, PhD(c)

Science: Primary qualitative data collection: Interviewing techniques for content creation: e-Voices of Patients and Podcasts with scientific leaders, Customer Surveys design and collateral marketing communication content production

Business: Global communications consultant in pharmaceuticals/health care and biotechnology

Business Development responsibilities @LPBI: Monthly Newsletter and e-Voices Podcasts, emergence of an Audio & Video Library

2020-2021 RESULTS:

Newsletter #1 (February), #2 (March), #3 (June), #4 (September).

• February issue garnered 274 views on my LinkedIn page.
• March issue garnered 319 views on my LinkedIn page.
• June issue garnered  266 views on my LinkedIn page.
• September issue garnered 411 views on my LinkedIn page.

Posting regularly to Journal + Coronavirus Portal on Global Voices.

Posting regularly to social media channels.

E-Book Posting:

• April/May: My LinkedIn post about the 3D BioPrinting technology / podcast / e-book resulted in 741 views, most of which hit in less than 12 hours after the posting. This is significant for many reasons, including that the post was focused, impactful.
• As a result of my LinkedIn post, the LinkedIn group, JLM-BioCity, invited me to join their group of 250 life science companies in the Jerusalem area and over 2,000 members, mainly investors, C-level executives of bio companies. They also asked me to post my LinkedIn post on their Facebook page.

Podcasts:

Development Plan for e-VOICES Podcasting, 2019 – 2021*

https://pharmaceuticalintelligence.com/audio-podcasts/

Podcast Interviewer	INTERVIEWEE(S)	Subject	Date	Audio/Video/ Narrator
Gail S. Thornton	Dr. Stephen J. Williams, Dr. Irina Robu & Dr. Aviva Lev-Ari	3D BioPrinting in Medicine	5/2019	Audio
Gail S. Thornton	Prof. Feldman	Evolution Biology and Population Genetics	3/17/2020	Audio
Gail S. Thornton	Dr. Larry H. Bernstein, MD, FCAP	Life Memoirs in Clinical Pathology Told	8/2020	Audio Narrator: Dr. S.J. Williams
Gail S. Thornton	Dr. Justin D. Pearlman, MD, PhD	Cardiac Imaging – Evolution of Diagnostic Methods	4Q 2020	Audio
Gail S. Thornton	Dr. Raphael Nir	From Big Pharma to Biotech Entrepreneurship	2021	Audio
Gail S. Thornton	Dr. Meg Baker	GlycoBiology in Practice	2021	Audio
Gail S. Thornton	Dr. Ofer Markman	Memories of Procognia	2021	Audio

*Dr. Williams and Aviva – will have their Podcasts in 2021.

Worked with Dr. Irina Robu on BioPrinting thought leader post which garnered 94 views on my LinkedIn page.

Editing: Content for LPBI Wikipedia page + A. Lev-Ari Wikipedia page.

Media Pitching: LPBI story + BioPrinting story to medical/scientific trade magazines.

Professional Development: Attended Logan Science Journalism program Webinar (July).

Roles on 2.0 LPBI Group’s TNS #1,2,3,4,5,6 https://pharmaceuticalintelligence.com/vision/

• PENDING

TNS #1: TEXT Analysis on our CONTENTS: NLP, ML, AI – INSIGHTS MEAN VALUE and Up-selling content = NEW WARES to be brought to the market

TNS #2: Blockchain Transactions and broadcasting to communities in the Health Care Sector – THE ONLY WAY TO MONETIZE our content by narrow casting to Health Care Communities: BustIQ – lined them up and are willing to build the Front End

TNS #3: Podcasts – will not be a Money maker – will be a Reputation Builder – very important in Pharmaceutical MEDIA – SEE Table above

TNS #4: Conversion e-Books to Audio and Articles to SoundCloud Audio files – Text to Audio  [SEE New Yorker] – HAS POTENTIAL

TNS #5: Joint venture with Dr. Nir for Drug Discovery: 

TNS #6:  e-Books Translations into Japanese, Spanish, Russian 

Plan for Business Development Activity at 1.0 LPBI 4Q 2020

• PENDING

Plan for Business Development Activity at 2.0 LPBI 1Q 2021

• PENDING